Michael Golembiewski
2022
In 2022, Michael Golembiewski earned a total compensation of $1.1M as Chief Financial Officer at Apricus Biosciences, a 6% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $126,850 |
|---|---|
| Option Awards | $616,800 |
| Salary | $317,125 |
| Other | $10,852 |
| Total | $1,071,627 |
Golembiewski received $616.8K in option awards, accounting for 58% of the total pay in 2022.
Golembiewski also received $126.9K in non-equity incentive plan, $317.1K in salary and $10.9K in other compensation.
Rankings
In 2022, Michael Golembiewski's compensation ranked 2,881st out of 5,736 executives tracked by ExecPay. In other words, Golembiewski earned more than 49.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,881 out of 5,736 | 50th |
Division Manufacturing | 1,610 out of 3,125 | 49th |
Major group Chemicals And Allied Products | 748 out of 1,416 | 47th |
Industry group Drugs | 698 out of 1,317 | 47th |
Industry Pharmaceutical Preparations | 506 out of 963 | 48th |
Source: SEC filing on April 12, 2023.
Golembiewski's colleagues
We found one more compensation record of an executive who worked with Michael Golembiewski at Apricus Biosciences in 2022.
2022
Raj Mehra
Apricus Biosciences